It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Microcirculatory dysfunction has been observed in patients who have suffered septic shock or cardiogenic shock, and in patients who have undergone surgery [5–9]. [...]microcirculatory dysfunction is associated with poor prognosis in patients with severe sepsis and in patients who have suffered an out-of-hospital cardiac arrest [10–12]. Because information regarding the association between microcirculatory dysfunction and prognosis in patients with VA-ECMO support is limited [13], this study focused on comparing perfused small vessel density (PSVD) between 28-day nonsurvivors and survivors by visualizing their microcirculation using a third-generation video microscope within 12 h after VA-ECMO placement [14, 15]. According to the suggestions of a previously held roundtable conference for evaluating the microcirculation [20], the following parameters were investigated: a) total small vessel (less than 20 μm) density (TSVD); b) perfused small vessel density (PSVD); c) proportion of perfused vessels (PPV); d) microvascular flow index (MFI) score; and e) heterogeneity index (HI). According to the ROC curve analysis, the threshold values of the APACHE II score, lactate level, PSVD, and PPV were 22.5, 7.5 mmol/l, 16.2 mm/mm2, and 76.5%, respectively.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer